Article Information
History
- August 21, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Cancer Research UK Clinical Trials Unit, University of Birmingham, UK
- 2Institute of Cancer and Genomic Sciences, University of Birmingham, UK
- 3Mailman School of Public Health, Columbia University, New York, NY, USA
- ↵*Corresponding author; email: k.brock{at}bham.ac.uk